Signal Brazil's GLP-1 patents expired in March 2026 and price is the stated barrier for 35% of interested consumers
Summary
McKinsey reports Brazilian patent expirations in March 2026 opening the way to cheaper GLP-1 options, with 35 percent of interested consumers citing price as the reason they are not using them and 44 percent saying lower post-expiry prices would make them more likely to start, against a market McKinsey sizes at about 3 billion dollars and three million consumers.
Classification
Main topicBio & Health Tech
Region menusGlobal
Occurrencescope:country · geo_region:latin_america · country:BR
Impactscope:global
Time horizon0-3 years (2026-07-26)
Last updated2026-07-29 04:49:52
Evidence 1
- State of the Consumer 2026: When tech acceleration and cost pressures collide McKinsey & Company page=10;section=Chapter 2: The health revolution - Wearables and scientific breakthroughs are influencing consumer goals 2026-06 accessed 2026-07-26
Part of trends 1
Directly linked issues 0
No objects.
Relation types: supports
Public id: fm-5688f4a93525